| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | SC TO-T/A |
| 06 Nov 2026 | SCHEDULE 13G/A |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – Nov. 5, 2026 – Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced its third-quarter 2026 financial results. |
| 30 Oct 2026 | SC TO-T |
| 08 Oct 2026 | SC TO-C |
| 08 Oct 2026 | SC TO-C |
| 08 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
This Agreement and Plan of Merger (this “Agreement”) is made and entered into as of October 8, 2026 (the “Agreement Date”), by and among Viatris Inc., a Delaware corporation (“Parent”), Peach Purchaser Sub Inc., a Delaware corporation an... |
| 02 Oct 2026 |
Form 4: Groothuis Leo Frans, Director
Granted 2,469 Deferred Stock Units ($43.8K) |
| 02 Oct 2026 |
Form 4: Simmons David S, Director
Granted 2,117 Deferred Stock Units ($37.5K) |
| 08 Sep 2026 | SCHEDULE 13G/A |
| 18 Aug 2026 |
Form 4: Enrietti Andrew, See Remarks
Received 26,133 shares by exercise or conversion · Gave up 11,366 shares to cover exercise price or tax ($184K) |
| 12 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | SCHEDULE 13G |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – August 6, 2026 – Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced its second-quarter 2026 financial results. |
| 01 Jul 2026 |
Form 4: Simmons David S, Director
Granted 2,362 Deferred Stock Units ($37.5K) |
| 01 Jul 2026 |
Form 4: Groothuis Leo Frans, Director
Granted 2,756 Deferred Stock Units ($43.8K) |
| 01 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Not Partnerships For U.S. Federal Income Tax Purposes) |
Loading...